Effects of aromatherapy on patient satisfaction with procedural abortion at less than 10 weeks’ gestation: A randomized controlled trial

Abstract

ObjectivesThis study aimed to compare satisfaction with procedural abortion prior to 10 weeks’ gestation in patients randomized to lavender essential oil aromatherapy vs placebo (jojoba oil). Study designThis randomized trial compared lavender aromatherapy vs placebo in patients undergoing procedural abortion <10 weeks’ gestation. Participants self-administered and inhaled oil during their procedures. Our primary outcome was composite mean score on the Iowa Satisfaction with Anesthesia Scale. Participants completed the State-Trait Anxiety Inventory, a visual analog scale reporting maximum procedural pain, and reported postprocedure aromatherapy acceptability. ResultsWe analyzed 112 participants randomized to aromatherapy (n = 57) vs placebo (n = 55). Baseline characteristics were similar between groups. We found no difference in overall satisfaction (mean Iowa Satisfaction with Anesthesia Scale scores aromatherapy: 0.72 ± 0.96 vs placebo: 0.46 ± 0.98, p = 0.17) or maximum procedural pain (median visual analog scale score aromatherapy: 65 [range: 4–95] vs placebo: 63 [range: 7–97], p = 0.91). Independent predictors of satisfaction included the use of oral sedation (B: 0.36; 95% CI: 0.04–0.69), state anxiety (B: −0.45; 95% CI: −0.79 to −0.10), and maximum procedural pain (B: −0.17; 95% CI: −0.25 to −0.09). The aromatherapy participants were significantly more likely to have found inhaling scented oil helpful during their procedure (71.9% vs 45.5%; p = 0.005) and would recommend it to a friend who needed a procedural abortion (86.0% vs 56.4%; p = 0.0005) compared to those in the placebo group. Additionally, patients in the aromatherapy group were significantly more likely to agree with the statement, “If I need another procedural abortion, I would want to inhale scented oil during my procedure” (87.7% vs 70.9%; p = 0.03). ConclusionsThe adjunctive use of lavender aromatherapy during first-trimester procedural abortion does not improve satisfaction with anesthesia but is highly valued by patients. ImplicationsOral opioids as an adjunct to standard analgesics during procedural abortion (ibuprofen and paracervical block) do not decrease pain, and nonopioid options are lacking. Given current limited anesthesia options, aromatherapy could serve as an affordable and acceptable nonopioid adjunct to current standard of care during procedural abortion. ClinicalTrials.gov IdentifierNCT04969900.